MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Munshi, R.
Right arrow Articles by Brooker, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Munshi, R.
Right arrow Articles by Brooker, G.

P2U-purinergic receptors on C6-2B rat glioma cells: modulation of cytosolic Ca2+ and cAMP levels by protein kinase C

R Munshi, MA DeBernardi and G Brooker

Department of Biochemistry and Molecular Biology, Georgetown University School of Medicine, Washington, DC 20007.

The activation of P2-purinergic receptors on C6-2B rat glioma cells caused a transient increase in cytosolic-free Ca2+ concentration ([Ca2+]i) as detected by Fura 2 fluorescence ratio imaging of single cells. These purinergic receptors are of the P2U subtype because UTP and ATP were equipotent and substantially more potent than the P2X- and P2Y-selective agonists alpha,beta-methylene ATP and 2-methylthio ATP, respectively. There was homologous desensitization of the Ca2+ responses between UTP and ATP but no heterologous desensitization between these nucleotides and another Ca(2+)-mobilizing receptor agonist, alpha-thrombin. The UTP-induced peak [Ca2+]i rise was insensitive to chelation of extracellular Ca2+ with EGTA. However, the response was abolished after either depletion of intracellular Ca2+ stores with the microsomal Ca(2+)-ATPase inhibitor thapsigargin or blockade of Ca2+ release from intracellular stores with the muscle relaxant dantrolene. The activation of P2U-purinergic receptors and thrombin receptors increased the formation of total inositol phosphates (IPs) and inhibited cAMP accumulation elicited with either the beta- adrenergic receptor agonist (-)-isoproterenol, or forskolin, a direct activator of adenylyl cyclase. UTP- and alpha-thrombin-induced changes in the levels of IPs, cytosolic Ca2+, and agonist-elicited cAMP accumulation were dramatically inhibited (> 80%) by acute treatment of the cells with the protein kinase C activator 4 beta-phorbol 12- myristate 13-acetate but not with the inactive ester 4 alpha-phorbol 12,13-didecanoate. We conclude that in C6-2B cells, the increase in [Ca2+]i after activation of P2U-purinergic receptors is primarily a result of IPs-mediated release of Ca2+ from intracellular stores with secondary influx of Ca2+ by capacitative mechanisms. Also, the inhibition by UTP and alpha-thrombin of agonist-elicited cAMP accumulation is mediated through an increase in [Ca2+]i.

Volume 44, Issue 6, pp. 1185-1191, 12/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. J. Perez-Garcia, V. Cena, Y. de Pablo, M. Llovera, J. X. Comella, and R. M. Soler
Glial Cell Line-derived Neurotrophic Factor Increases Intracellular Calcium Concentration: ROLE OF CALCIUM/CALMODULIN IN THE ACTIVATION OF THE PHOSPHATIDYLINOSITOL 3-KINASE PATHWAY
J. Biol. Chem., February 13, 2004; 279(7): 6132 - 6142.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C.-J. Tai, S. K. Kang, and P. C. K. Leung
Adenosine Triphosphate-Evoked Cytosolic Calcium Oscillations in Human Granulosa-Luteal Cells: Role of Protein Kinase C
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 773 - 777.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. R. Post, L. C. Rump, A. Zambon, R. J. Hughes, M. D. Buda, J. P. Jacobson, C. C. Kao, and P. A. Insel
ATP Activates cAMP Production via Multiple Purinergic Receptors in MDCK-D1 Epithelial Cells. BLOCKADE OF AN AUTOCRINE/PARACRINE PATHWAY TO DEFINE RECEPTOR PREFERENCE OF AN AGONIST
J. Biol. Chem., September 4, 1998; 273(36): 23093 - 23097.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Ralevic and G. Burnstock
Receptors for Purines and Pyrimidines
Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W.-M. Zhang and T.-M. Wong
Suppression of cAMP by phosphoinositol/Ca2+ pathway in the cardiac kappa -opioid receptor
Am J Physiol Cell Physiol, January 1, 1998; 274(1): C82 - C87.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Bohm, L. M. Khitin, E. F. Grady, G. Aponte, D. G. Payan, and N. W. Bunnett
Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2
J. Biol. Chem., September 6, 1996; 271(36): 22003 - 22016.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. De Bernardi, S. J. Rabin, A. M. Colangelo, G. Brooker, and I. Mocchetti
trkA Mediates the Nerve Growth Factor-induced Intracellular Calcium Accumulation
J. Biol. Chem., March 15, 1996; 271(11): 6092 - 6098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Post, J. P. Jacobson, and P. A. Insel
P(2) Purinergic Receptor Agonists Enhance cAMP Production in Madin-Darby Canine Kidney Epithelial Cells via an Autocrine/Paracrine Mechanism
J. Biol. Chem., January 26, 1996; 271(4): 2029 - 2032.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Chiono, R. Mahey, G. Tate, and D. M. F. Cooper
Capacitative Ca[IMAGE] Entry Exclusively Inhibits cAMP Synthesis in C6-2B Glioma Cells
J. Biol. Chem., January 20, 1995; 270(3): 1149 - 1155.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics